tradingkey.logo

AtriCure Inc

ATRC
查看詳細走勢圖
37.110USD
+0.910+2.51%
收盤 02/06, 16:00美東報價延遲15分鐘
1.84B總市值
虧損本益比TTM

AtriCure Inc

37.110
+0.910+2.51%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+2.51%

5天

+0.49%

1月

-11.16%

6月

+3.37%

今年開始到現在

-6.19%

1年

-9.49%

查看詳細走勢圖

TradingKey AtriCure Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

AtriCure Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名36/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為52.78。中期看,股價處於上升通道。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

AtriCure Inc評分

相關信息

行業排名
36 / 205
全市場排名
124 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看跌

AtriCure Inc亮點

亮點風險
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
業績高增長
公司營業收入穩步增長,連續3年增長40.84%
估值低估
公司最新PE估值-61.07,處於3年歷史低位
機構減倉
最新機構持股49.59M股,環比減少0.21%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉345.00股

分析師目標

基於 9 分析師
買入
評級
52.778
目標均價
+43.42%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

AtriCure Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

AtriCure Inc簡介

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
公司代碼ATRC
公司AtriCure Inc
CEOCarrel (Michael H)
網址https://www.atricure.com
KeyAI